THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,620 | +154.4% | 18,300 | 0.0% | 0.00% | – |
Q2 2023 | $10,069 | -18.8% | 18,300 | 0.0% | 0.00% | – |
Q1 2023 | $12,406 | -85.4% | 18,300 | 0.0% | 0.00% | – |
Q3 2022 | $85,000 | -8.6% | 18,300 | 0.0% | 0.00% | – |
Q2 2022 | $93,000 | -28.5% | 18,300 | 0.0% | 0.00% | – |
Q1 2022 | $130,000 | – | 18,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Triatomic Management LP | 517,479 | $853,840 | 0.72% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 104,400 | $172 | 0.25% |
Prosight Management, LP | 275,561 | $454,676 | 0.25% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,360,052 | $5,544,086 | 0.12% |
Redmile Group, LLC | 1,583,158 | $2,612,211 | 0.11% |
Alpine Global Management, LLC | 46,326 | $76 | 0.02% |
Saba Capital Management, L.P. | 174,513 | $287,946 | 0.00% |
FMR LLC | 12,001,982 | $19,803,270 | 0.00% |
Leucadia National | 192,452 | $317,546 | 0.00% |
BANK OF AMERICA CORP /DE/ | 31,995 | $52,792 | 0.00% |